1. 徐兵河 中国 中国医学科学院 2021中国工程院院士 TROPION-Breast01: Datopotamab deruxtecan vs chemotherapy in pre-treated inoperable or metastatic HR+..
2. 甄永苏 中国 中国医学科学院 中国工程院院士 hIMB1636-MMAE, a Novel TROP2-Targeting Antibody-Drug Conjugate Exerting Potent Antitumor Efficacy in..
3. 徐兵河 中国 中国医学科学院 2021中国工程院院士 A Phase IIb, single arm, multicenter trial of sacituzumab govitecan in Chinese patients with metasta..
4. 高福 中国 浙江大学 2019美国医学院院士;中国科学院院士;2019美国科学院院士 Structural insights into the cis and trans assembly of human trophoblast cell surface antigen 2
5. Aditya,Bardia 美国 Harvard University TROPION-Breast01: Datopotamab deruxtecan vs chemotherapy in pre-treated inoperable or metastatic HR+..
6. Seock-Ah,Im 韩国 Seoul National University TROPION-Breast01: Datopotamab deruxtecan vs chemotherapy in pre-treated inoperable or metastatic HR+..
7. Javier,Cortes 西班牙 IOB Institute oncology Correlation between trophoblast cell-surface antigen-2 (Trop-2) expression and pathological complete..
8. Giuseppe,Curigliano 意大利 University of Milan Breaking barriers in triple negative breast cancer (TNBC) - Unleashing the power of antibody-drug co..
9. Danesi, Romano 意大利 University of Pisa Breaking barriers in triple negative breast cancer (TNBC) - Unleashing the power of antibody-drug co..
10. Del Mastro, Lucia 意大利 University of Genoa Breaking barriers in triple negative breast cancer (TNBC) - Unleashing the power of antibody-drug co..
11. Valentina,Guarneri 意大利 University of PADUA Breaking barriers in triple negative breast cancer (TNBC) - Unleashing the power of antibody-drug co..
12. Santini, Daniele 意大利 Campus Biomed University Rome Breaking barriers in triple negative breast cancer (TNBC) - Unleashing the power of antibody-drug co..
13. Puglisi, Fabio 意大利 University of Udine Breaking barriers in triple negative breast cancer (TNBC) - Unleashing the power of antibody-drug co..
14. 黄钢 中国 上海健康医学院 博士生导师 ImmunoPET imaging of Trop2 expression in solid tumors with nanobody tracers
15. Jukka,Westermarck 芬兰 University of Turku CIP2A coordinates phosphosignaling, mitosis, and the DNA damage response
16. Ahmad,Awada 比利时 Université Libre De Bruxelles, Ulb Pharmacokinetics and pharmacodynamics of antibody-drug conjugates for the treatment of patients with..
17. Lai, Raymond 加拿大 University of Alberta ULK2 Is a Key Pro-Autophagy Protein That Contributes to the High Chemoresistance and Disease Relapse..
18. Larry,Fliegel 加拿大 University of Alberta The Relationship between Trop-2, Chemotherapeutic Drugs, and Chemoresistance
19. Suzanne M,Garland 澳大利亚 University of Melbourne Development of a touchdown droplet digital PCR assay for the detection and quantitation of human pap..
20. Glen,Kristiansen 德国 University of Bonn TROP-2 is widely expressed in vulvar squamous cell carcinoma and represents a potential new therapeu..